Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women Q Abdool Karim, SS Abdool Karim, JA Frohlich, AC Grobler, C Baxter, ... Science 329 (5996), 1168-1174, 2010 | 2380 | 2010 |
Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women QA Karim, SSA Karim, JA Frohlich, AC Grobler, C Baxter, LE Mansoor, ... Science (New York, NY) 329 (5996), 1168, 2010 | 1605 | 2010 |
Timing of initiation of antiretroviral drugs during tuberculosis therapy SS Abdool Karim, K Naidoo, A Grobler, N Padayatchi, C Baxter, A Gray, ... New England Journal of Medicine 362 (8), 697-706, 2010 | 925 | 2010 |
Integration of antiretroviral therapy with tuberculosis treatment SS Abdool Karim, K Naidoo, A Grobler, N Padayatchi, C Baxter, AL Gray, ... New England Journal of Medicine 365 (16), 1492-1501, 2011 | 650 | 2011 |
Tenofovir gel for the prevention of herpes simplex virus type 2 infection SS Abdool Karim, Q Abdool Karim, ABM Kharsany, C Baxter, AC Grobler, ... New England Journal of Medicine 373 (6), 530-539, 2015 | 118 | 2015 |
Long-term adherence to antiretroviral therapy in a South African adult patient cohort: a retrospective study A Moosa, TN Gengiah, L Lewis, K Naidoo BMC infectious diseases 19, 1-12, 2019 | 97 | 2019 |
Genital tenofovir concentrations correlate with protection against HIV infection in the CAPRISA 004 trial: importance of adherence for microbicide effectiveness ADM Kashuba, TN Gengiah, L Werner, KH Yang, NR White, QA Karim, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 69 (3), 264-269, 2015 | 89 | 2015 |
The influence of tuberculosis treatment on efavirenz clearance in patients co-infected with HIV and tuberculosis TN Gengiah, NHG Holford, JH Botha, AL Gray, K Naidoo, ... European journal of clinical pharmacology 68, 689-695, 2012 | 64 | 2012 |
Adherence challenges with drugs for pre-exposure prophylaxis to prevent HIV infection TN Gengiah, A Moosa, A Naidoo, LE Mansoor International journal of clinical pharmacy 36, 70-85, 2014 | 62 | 2014 |
A qualitative study of patient motivation to adhere to combination antiretroviral therapy in South Africa F van Loggerenberg, D Gray, S Gengiah, P Kunene, TN Gengiah, ... AIDS patient care and STDs 29 (5), 299-306, 2015 | 59 | 2015 |
Low rifampicin concentrations in tuberculosis patients with HIV infection TN Gengiah, JH Botha, D Soowamber, K Naidoo, SSA Karim The Journal of Infection in Developing Countries 8 (08), 987-993, 2014 | 44 | 2014 |
Recruitment of high risk women for HIV prevention trials: baseline HIV prevalence and sexual behavior in the CAPRISA 004 tenofovir gel trial QA Karim, ABM Kharsany, JA Frohlich, C Baxter, N Yende, LE Mansoor, ... Trials 12, 1-8, 2011 | 42 | 2011 |
Implementing isoniazid preventive therapy in a tuberculosis treatment-experienced cohort on ART B Maharaj, TN Gengiah, N Yende-Zuma, S Gengiah, A Naidoo, K Naidoo The International Journal of Tuberculosis and Lung Disease 21 (5), 537-543, 2017 | 36 | 2017 |
Assessing the safety and pharmacokinetics of the anti-HIV monoclonal antibody CAP256V2LS alone and in combination with VRC07-523LS and PGT121 in South African women: study … S Mahomed, N Garrett, QA Karim, NY Zuma, E Capparelli, C Baxter, ... BMJ open 10 (11), e042247, 2020 | 32 | 2020 |
Initiating antiretrovirals during tuberculosis treatment: a drug safety review TN Gengiah, AL Gray, K Naidoo, QA Karim Expert opinion on drug safety 10 (4), 559-574, 2011 | 32 | 2011 |
Individualised motivational counselling to enhance adherence to antiretroviral therapy is not superior to didactic counselling in South African patients: findings of the … F van Loggerenberg, AD Grant, K Naidoo, M Murrman, S Gengiah, ... AIDS and behavior 19, 145-156, 2015 | 31 | 2015 |
A drug evaluation of 1% tenofovir gel and tenofovir disoproxil fumarate tablets for the prevention of HIV infection TN Gengiah, C Baxter, LE Mansoor, ABM Kharsany, SS Abdool Karim Expert opinion on investigational drugs 21 (5), 695-715, 2012 | 31 | 2012 |
Changes to antiretroviral drug regimens during integrated TB–HIV treatment: results of the SAPiT trial A Naidoo, K Naidoo, N Yende-Zuma, TN Gengiah, N Padayatchi, AL Gray, ... Antiviral therapy 19 (2), 161-169, 2014 | 27 | 2014 |
Co-enrollment in multiple HIV prevention trials—Experiences from the CAPRISA 004 Tenofovir gel trial QA Karim, ABM Kharsany, K Naidoo, N Yende, T Gengiah, Z Omar, ... Contemporary clinical trials 32 (3), 333-338, 2011 | 27 | 2011 |
CAPRISA 018: a phase I/II clinical trial study protocol to assess the safety, acceptability, tolerability and pharmacokinetics of a sustained-release tenofovir alafenamide … TN Gengiah, QA Karim, I Harkoo, L Mansoor, NY Zuma, P Radebe, ... BMJ open 12 (1), e052880, 2022 | 20 | 2022 |